ArticleJournal of Cancer2024

Pan-cancer analysis suggests that LY6H is a potential biomarker of diagnosis, immunoinfiltration, and prognosis.

Haifei Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.